Replies to post #32045 on Ariad Pharmaceuticals Inc fka ARIA

[vidpok45]

Thank you Doug and Jaybe. 12800 patients who might benefit from Ponatinib for RET in addition to all the other indications is something to consider. Fast forward five years and Ponatinib could be a 5 billion dollar drug.